secwatch.observer — SEC 8-K summary
======================================

Issuer:     HealthLynked Corp (HLYK)
CIK:        0001680139
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001213900-25-121170
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HealthLynked appoints COO and adds two directors; targets Nasdaq uplist in 2026
-------------------------------------------------------------------------------

- Duncan McGillivray appointed COO effective Dec 8, 2025; base salary $120K/yr, rising to $150K on Nasdaq uplist.
- McGillivray receives RSU grant of up to 180K shares: 90K vest ratably over 3 years, 90K upon Nasdaq uplist.
- Jason Bishara and Chris G. Pulos appointed to Board effective Dec 1, 2025; each receives $20K annual compensation in shares.
- Company plans to uplist to Nasdaq Capital Market in 2026, with McGillivray overseeing capital strategy and investor relations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680139/000121390025121170/0001213900-25-121170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680139/000121390025121170/ea0269326-8k_health.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-121170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer